BTAI - BioXcel Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart

BTAI is currently covered by 7 analysts with an average potential upside of $16.78 (71.51%) backed by displayed 25 price targets and 75 ratings.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 53.61% with an average time for these price targets to be met of 69.5 days.

Highest price target for BTAI is 33, Lowest price target is 3, average price target is 18.

Most recent stock forecast was given by ROBYN KARNAUSKAS from TRUIST on 05-Oct-2023. First documented stock forecast 03-May-2018.

Currently, out of the existing stock ratings of BTAI - 2 which are a Sell (5.88%), 26 which are a Buy (76.47%), 6 which are a Hold (17.65%)

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

1 months 25 days ago

1/1 (100%)

$-12.97 (-35.08%)

27

Buy

11

$8.47 (334.78%)

11

2 months 17 days ago

0/12 (0%)

$33.3 (229.11%)

Hold

4

$0.09 (2.30%)

4

3 months 7 days ago

7/9 (77.78%)

$4.68 (16.79%)

48

Buy

3 months 15 days ago

1/3 (33.33%)

$17.73 (63.94%)

45

Hold

4

$0.09 (2.30%)

13

3 months 15 days ago

6/8 (75%)

$-0.11 (5.42%)

45

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BTAI (BioXcel Therapeutics) average time for price targets to be met?

On average it took 69.5 days on average for the stock forecasts to be realized with a an average price target met ratio 53.61

Which analyst has the current highest performing score on BTAI (BioXcel Therapeutics) with a proven track record?

DO KIM

Which analyst has the most public recommendations on BTAI (BioXcel Therapeutics)?

Do Kim works at PIPER SANDLER and has 4 price targets and 7 ratings on BTAI

Which analyst is the currently most bullish on BTAI (BioXcel Therapeutics)?

Geoff Meacham with highest potential upside - $40.57

Which analyst is the currently most reserved on BTAI (BioXcel Therapeutics)?

Sumant Kulkarni with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart